Back to CVE records
High 7.5Published Jul 2, 2026

CVE-2026-50722IKEv2 Denial of Service via RSA-SHA1 (PKCS#1 RSASSA-PKCS1-v1_5) authentication payload

Updated under an hour ago ()

Does this affect you?

It affects The Libreswan Project libreswan and 1 other product. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

Libreswan, via the function RSA_authenticate_hash_signature_pkcs1_1_5_rsa(), did not correctly verify the DER encoding of the ASN.1 digest when the IKEv2 AUTH payload was encoded using RSASSA-PKCS1-v1_5 (RFC 8017). A remote attacker can use a variation on the Bleichenbacher attack to forge the AUTH payload when small public exponents are used (e.g., e=3), leading to impersonation. Additionally, a remote attacker, by encoding a shorter than expected hash in the AUTH payload, could trigger an assertion leading to denial-of-service. The daemon aborts and restarts; continued exploitation causes sustained denial of service. Remote code execution is not possible. X.509 certificate verifications of the remote IKE peer are not affected.

CVSS
7.5 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Weakness (CWE)
CWE-347, CWE-617
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
libreswan
NVD analysis
Analyzed
Record last updated
Jul 7, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
The Libreswan Project libreswan
libreswan_project:libreswan (from the name)
through 5.3; 5.3.1 not affected
CNA record
libreswan libreswan
libreswan:libreswan
before 5.3.1
NVD

References

References

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.